Labskin Team to present and attend at the Microbiome Movement Skin Health & Dermatology Digital Event, August 3rd-5th 2021.
The Labskin team is proud to be a partner of this event, joining other microbiome leaders such as Eagle Genomics, Boston Analytical and Therapeutics Inc. The theme for this event is “Translating scientific findings of the Skin Microbiome into commercially viable therapeutics & cosmetic products that improve skin health”.
In its fourth year, this event continues to unite researchers from both academia and industry, hoping to fast-track the development of microbiome-targeting therapeutics and cosmetics that focus on characterization, clinical testing and product commercialization.
Eric Clarke, Labskin’s Head of Sales will speak on the 1st day of the event, under the banner of Harnessing In Vivo & Ex Vivo Skin Models for Development. The topic of Eric’s presentation is “Artificial Intelligence & Clones – Labskin AI for the Future of Skincare”.
The presentation will consist of three main areas:
- Highlighting the Labskin platform
- Exploring how to clone the human microbiome
- Harnessing AI for skin microbiome data analysis
Also in attendance from Labskin will be Christofer Kaprelian, Senior Business Development Manager, Dr David Caballero-Lima, Head of R&D, and Louise Doyle, Sales & Marketing Coordinator all of whom will be delighted to connect with other attendees during the Virtual Networking Sessions.
To find out more about the event, and to register to attend, please visit the event website: Microbiome Movement – Skin Health & Dermatology Summit.